Biblio
Export 363 results:
Author Title [ Type] Year Filters: First Letter Of Last Name is E [Clear All Filters]
“Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 105-114, 2018.
, “Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”, J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
, “Patterns of Regional Cerebral Blood Flow as a Function of Age Throughout the Lifespan.”, J Alzheimers Dis, 2018.
, “Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 473-484, 2017.
, “Pathogenomic Signature and Aberrant Neurogenic Events in Experimental Cerebral Ischemic Stroke: A Neurotranscriptomic-Based Implication for Dementia.”, J Alzheimers Dis, vol. 94, no. s1, pp. S289-S308, 2023.
, “Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1103-1122, 2022.
, “Oxygen and Glucose Deprivation Alter Synaptic Distribution of Tau Protein: The Role of Phosphorylation.”, J Alzheimers Dis, vol. 60, no. 2, pp. 593-604, 2017.
, “Olfactory Function is Associated with Cognitive Performance: Results of the Heinz Nixdorf Recall Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 319-329, 2018.
, “N-Terminal Pro-B Type Natriuretic Peptide is Associated with Mild Cognitive Impairment in the General Population.”, J Alzheimers Dis, vol. 55, no. 1, pp. 359-369, 2017.
, “NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.”, J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.
, “A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 2, pp. 731-45, 2016.
, “Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.”, J Alzheimers Dis, vol. 55, no. 1, pp. 159-170, 2017.
, “Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression.”, J Alzheimers Dis, vol. 55, no. 2, pp. 763-776, 2017.
, “Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression.”, J Alzheimers Dis, vol. 55, no. 2, pp. 763-776, 2017.
, “Neuropsychiatric Symptoms in Patients with Neurocognitive Disorder and Their Performance Between Mild and Major Stages.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1735-1744, 2021.
, “Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer's Disease: A Case Report.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1363-1369, 2018.
, “Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms.”, J Alzheimers Dis, vol. 59, no. 1, pp. 141-153, 2017.
, “Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.”, J Alzheimers Dis, vol. 73, no. 1, pp. 333-345, 2020.
, “Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 115-126, 2018.
, “Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.”, J Alzheimers Dis, vol. 95, no. 1, pp. 307-316, 2023.
, “Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations.”, J Alzheimers Dis, vol. 53, no. 1, pp. 303-13, 2016.
, “Neural Correlates of Self-Reference Effect in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 2, pp. 717-731, 2017.
, “Neural Correlates of Self-Reference Effect in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 2, pp. 717-731, 2017.
, “Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
, “Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.”, J Alzheimers Dis, vol. 51, no. 1, pp. 165-78, 2016.
,